Safety of metamizole analgesic therapy in patients with dyspepsia syndrome: a case report
The selection of drugs in patients who have experienced dyspepsia syndrome needs to be studied for its use. Non-steroidal anti-inflammatory drugs (NSAIDs) are a class of drugs that are effective in controlling various inflammatory conditions and treating inflammatory symptoms such as pain but are li...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Poltekkes Kemenkes Yogyakarta
2023-11-01
|
| Series: | Jurnal Teknologi Laboratorium |
| Subjects: | |
| Online Access: | https://teknolabjournal.com/index.php/Jtl/article/view/443 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The selection of drugs in patients who have experienced dyspepsia syndrome needs to be studied for its use. Non-steroidal anti-inflammatory drugs (NSAIDs) are a class of drugs that are effective in controlling various inflammatory conditions and treating inflammatory symptoms such as pain but are limited in their use in patients with dyspepsia. We report case of patients with metamizole NSAIDs during three days of hospitalization with a diagnosis of dyspepsia. Other side effects such as cardiovascular, neurological disorders and agranulocytosis can also occur with the use of metamizole. There were no side effects that exacerbated dyspepsia symptoms in patients or other side effects during the three days of using metamizol. It can be concluded that short-term metamizole therapy is safe for use in patients with dyspeptic syndrome. Concomitant use with gastric acid blocking agents such as H2 receptor antagonists may also reduce the effects of gastrointestinal disturbances. |
|---|---|
| ISSN: | 2338-5634 2580-0191 |